Literature DB >> 28625147

Adverse Drug Reactions Related to Drug Administration in Hospitalized Patients.

Luca Gallelli1, Antonio Siniscalchi2, Caterina Palleria1, Laura Mumoli1, Orietta Staltari1, Aida Squillace1, Francesca Maida1, Emilio Russo1, Santo Gratteri3, Giovambattista De Sarro1.   

Abstract

INTRODUCTION: Drug treatment may be related to the development of adverse drug reactions (ADRs). AIM: In this paper, we evaluated the ADRs in patients admitted to Catanzaro Hospital.
METHODS: After we obtained the approval by local Ethical Committee, we performed a retrospective study on clinical records from March 01, 2013 to April 30, 2015. The association between drug and ADR or between drug and drug-drug-interactions (DDIs) was evaluated using the Naranjo's probability scale and Drug Interaction Probability Scale (DIPS), respectively.
RESULTS: During the study period, we analyzed 2870 clinical records containing a total of 11,138 prescriptions, and we documented the development of 770 ADRs. The time of hospitalization was significantly higher (P<0.05) in women with ADRs (12.6 ± 1.2 days) with respect to men (11.8± 0.83 days). Using the Naranjo score, we documented a probable association in 78% of these reactions, while DIPS revealed that about 22% of ADRs were related to DDIs. Patients with ADRs received 3052 prescriptions on 11,138 (27.4%) having a mean of 6.1±0.29 drugs that was significantly higher (P<0.01) with respect to patients not experiencing ADRs (mean of 3.4±0.13 drugs). About 19% of ADRs were not diagnosed and were treated as new diseases.
CONCLUSION: Our results indicate that drug administration induces the development of ADRs also during the hospitalization, particularly in elderly women. Moreover, we also documented that ADRs in some patients are under-diagnosed, therefore, it is important to motivate healthcare to report the ADRs in order to optimize the patients' safety. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Retrospective study; adverse drug reactions; clinical records; drug-drug Interactions; patients; pharmacovigilance

Mesh:

Substances:

Year:  2017        PMID: 28625147     DOI: 10.2174/1574886312666170616090640

Source DB:  PubMed          Journal:  Curr Drug Saf        ISSN: 1574-8863


  6 in total

1.  Adverse Drug Reaction (ADR) as a Cause of Hospitalization at a Government Hospital in Saudi Arabia: A Prospective Observational Study.

Authors:  Nouf Alayed; Bushra Alkhalifah; Munirah Alharbi; Naief Alwohaibi; Maryam Farooqui
Journal:  Curr Drug Saf       Date:  2019

2.  Myotoxicity Induced by Antiepileptic Drugs: Could be a Rare but Serious Adverse Event?

Authors:  Antonio Siniscalchi; Scott Mintzer; Giovambattista De Sarro; Luca Gallelli
Journal:  Psychopharmacol Bull       Date:  2021-11-03

3.  Panitumumab Induced Forearm Panniculitis in Two Women With Metastatic Colon Cancer.

Authors:  Ciliberto Domenico; Ierardi Antonella; Caroleo Benedetto; Scalise Luigi; Cimellaro Antonio; Colangelo Lidia; Spaziano Giuseppe; Luca Gallelli
Journal:  Curr Drug Saf       Date:  2019

4.  Evaluation of drug interactions of saxagliptin with sildenafil in healthy volunteers.

Authors:  Rania Y Mansour; Radwa ElBorolossy; Sara M Shaheen; Nagwa A Sabri
Journal:  Eur J Clin Pharmacol       Date:  2022-10-10       Impact factor: 3.064

5.  Prevalence of potential drug-drug interactions and associated factors among outpatients and inpatients in Ethiopian hospitals: a systematic review and meta-analysis of observational studies.

Authors:  Wondim Ayenew; Getahun Asmamaw; Arebu Issa
Journal:  BMC Pharmacol Toxicol       Date:  2020-08-24       Impact factor: 2.483

Review 6.  Drug-Drug Interactions in Vestibular Diseases, Clinical Problems, and Medico-Legal Implications.

Authors:  Giulio Di Mizio; Gianmarco Marcianò; Caterina Palleria; Lucia Muraca; Vincenzo Rania; Roberta Roberti; Giuseppe Spaziano; Amalia Piscopo; Valeria Ciconte; Nunzio Di Nunno; Massimiliano Esposito; Pasquale Viola; Davide Pisani; Giovambattista De Sarro; Milena Raffi; Alessandro Piras; Giuseppe Chiarella; Luca Gallelli
Journal:  Int J Environ Res Public Health       Date:  2021-12-08       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.